14-day Premium Trial Subscription Try For FreeTry Free

These Are the Top 10 Holdings of David Kim

10:55pm, Monday, 06'th Mar 2023
David Kim is the founder and Chief Investment Officer of Ghost Tree Capital. Before founding Ghost Tree Capital in 2013, Kim worked as the portfolio manager at Diamondback Capital (Nov 2006 – Dec 20
The stock market is digesting recent inflation data and earnings reports. Where is the stock market headed next?
The biotech industry has a reputation for being a breeding ground for high-value mergers and acquisitions, which does not come as a surprise given the aggressive push by leading biotech companies to c
Yahoo Finance Live's Brad Smith discusses Monday's trending tickers, including Fisker, Zillow, Seagen, and Union Pacific.
These Durable Goods figures are preliminary, and subject to future revisions.
Biopharma giant Pfizer is eyeing an acquisition of Seagen, the Seattle area's biggest biotech company, according to a report in the Wall Street Journal Monday.
Yahoo Finance Live's Brad Smith summarizes three key topics in markets to pay attention to on Monday morning.
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss reports that Pfizer is in talks to acquire biotech firm Seagen in a $30 billion deal.
Seagen Inc (NASDAQ: SGEN) opened more than 10% up this morning on reports that Pfizer Inc (NYSE: PFE) is interested in buying the cancer therapies company.
Pfizer is in early talks to acquire cancer specialist Seagen, according to a report that sent SGEN stock flying on Monday. The post 'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A Takeov
Yahoo Finance Live's Julie Hyman reports that Pfizer is looking to acquire biotech firm Seagen in a $30 billion takeover deal.
Seagen (SGEN) may be acquired by the large-cap pharma company Pfizer at a valuation of more than $30 billion, according to a Wall Street Journal article. Seagen's stock is up 17% in pre-market hours i

Seagen stock jumps on Pfizer takeover talk

09:42am, Monday, 27'th Feb 2023
Pfizer Inc (NYSE:PFE) is reportedly in talks to buy Seagen Inc (Seattle Genetics, Inc. (NASDAQ:SGEN)), a cancer drug maker that was last year tied to a potential takeover by Merk before negotiations b
Pfizer is in early talks to acquire cancer drugmaker Seagen in a potentially multibillion-dollar deal, The Wall Street Journal reported Monday.
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that management will participate in a fireside chat at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE